ノバルティス acquires マリアナ・オンコロジー to accelerate precision radiotherapy for cancer treatment
Acquiring Company
Novartis
Acquired Company
Mariana Oncology
Switzerland
MassachusettsBiotechnologyHealth CarepharmaceuticalsDescription
マリアナ・オンコロジー, a fully integrated biotechnology company pioneering a new era of innovative radiopharmaceuticals for cancer patient treatment, announced its acquisition by ノバルティス for an upfront payment of $1 billion and up to $750 million upon milestone achievements. This acquisition will integrate Mariana Oncology's innovative radiopharmaceutical pipeline and platform with Novartis's established expertise in clinical development and commercialization, aiming to accelerate the transformation of cancer treatment.
Quick answer
Novartis is acquiring Mariana Oncology, announced May 2, 2024. Novartis is based in Switzerland.
- How much did Novartis pay for Mariana Oncology?
- The deal value was not disclosed.
- What does Novartis do?
- Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel.
- Where are Novartis and Mariana Oncology based?
- Novartis is based in Switzerland. Mariana Oncology is based in Massachusetts, United States.
- Who are the decision-makers at Novartis?
- Fundz holds 1 contact at Novartis. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in pharmaceuticals and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
- MangoRx Acquires Revolutionary Preventive Care Technology from Intramont Technologies (June 4, 2024)
- Alcanza Clinical Research completes acquisition of North Georgia Clinical Research to enhance research participation opportunities (June 3, 2024)
- Novo Holdings A/S to acquire Catalent, Inc. for $63.50 per share in cash (May 29, 2024)
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- LCI completes acquisition of certain assets of Pfizer Pakistan Limited and Pfizer Inc. to enhance pharmaceutical portfolio (May 20, 2024)
Who to call at Novartis, and when
When Novartis changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Novartis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Novartis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novartis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Novartis makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Mariana Oncology?
Mariana Oncology was acquired by Novartis, based in Switzerland. The deal was reported on May 2, 2024. Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel. Novartis is publicly traded (NVS) and operates in Biotechnology.
When did Novartis acquire Mariana Oncology?
Novartis's acquisition of Mariana Oncology was reported on May 2, 2024. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Mariana Oncology do?
マリアナ・オンコロジーは、標的ペプチドベース放射性リガンド療法（RLT）の分野で革新をもたらす企業です。同社は幅広いがん治療のための新規ペプチドベース放射医薬品の開発と製造に注力し、革新的な治療法の提供に取り組んでいます。 It is privately held, and is based in Massachusetts.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.